Publication
Psychosomatic Medicine
36(2):p 115-120
Abstract
Oxygen consumption, carbon dioxide production, and respiratory rate are significantly decreased during the practice of a new, easily-learned relaxation technique. The elements of the technique are a mental device to prevent distracting thoughts, a passive attitude, decreased muscle tonus, and a quiet environment which is as free of visual and auditory stimuli as possible. Sitting quietly with the eyes either open or closed failed to produce the same changes. These physiologic changes are consistent with an integrated hypothalamic response resulting in hypothesized decreased sympathetic activity. This response has recently been termed the “relaxation response.”
Web and Email Links
Related Listings
Journal
PLOS ONE
Introduction Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) can profoundly affect quality of life and are influenced by stress and resiliency. The impact of mind-body interventions (MBIs) on IBS and IBD patients has not previously been examined. Methods Nineteen IBS and 29 IBD patients were enrolled in a 9-week relaxation response based mind-body group intervention (RR-MBI), focusing on elicitation of the RR and cognitive skill building. Symptom questionnaires […]
Journal
Behavioral Medicine
To clarify the mechanisms of gender-related mind/body relationships, the authors analyzed the characteristics of 1,132 outpatients (848 women and 284 men) attending a mind/body medicine clinic. At entry in the program, the patients completed the Medical Symptom Checklist, Symptom Checklist-90 revised (SCL-90R), and Stress Perception Scale. Women reported 9 out of 12 symptoms (fatigue, insomnia, headache, back pain, joint or limb pain, palpitations, constipation, nausea, and dizziness) […]
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]

